After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Boston Scientific Corp is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Boston Scientific Corp is $147.84B. A total of 8.13 million shares were traded on the day, compared to an average of 5.78M shares.
In the most recent transaction, Sorenson John Bradley sold 4,119 shares of BSX for 90.02 per share on Jan 02 ’25. After the transaction, the EVP, Global Operations now owns 35,319 company shares. In a previous transaction on Jan 03 ’25, Sorenson John Bradley sold 2,342 shares at 89.86 per share. BSX shares that EVP, Global Operations owns now total 32,977.
Among the insiders who sold shares, Mirviss Jeffrey B. disposed of 7,152 shares on Jan 03 ’25 at a per-share price of $89.86. This resulted in the EVP&Pres, Periph Intervent holding 28,454 shares of BSX after the transaction. In another insider transaction, Brennan Daniel J. sold 9,689 shares at $89.86 per share on Jan 03 ’25. Company shares held by the EVP and CFO now total 223,921.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BSX has a high of $101.14 and a low of $59.85.
As of this writing, BSX has an earnings estimate of $0.66 per share for the current quarter. EPS was calculated based on a consensus of 26.0 estimates, with a high estimate of $0.68 per share and a lower estimate of $0.64.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $14.05, while its Total Shareholder’s Equity was $16.62B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.81.
